The 2nd CRISPR Medicine Conference 2025

Join us 8-11 April, 2025, at Booth #B1S to experience the future of CRISPR genome editing! Explore our complete design-to-analysis workflow solutions that are crafted to empower your CRISPR genome editing research.

We will have several experts in attendance to share with you how these solutions save you time and increase your efficiency.

Register today!

Speakers

Dr. Adam Chernick completed his Bachelor of Health Sciences in Biomedical Sciences and his PhD in Veterinary Medical Sciences at the University of Calgary, Canada. His doctoral research focused on the evolution of ssRNA viruses infecting cattle and relied heavily on basic molecular biology techniques as well as sophisticated methods, including next generation sequencing and phylogenetic analysis. Today, he works as a senior commercial product manager overseeing Integrated DNA Technologies (IDT) global CRISPR and functional genomics portfolio.

Ashley Jacobi currently leads the Genomic Medicine & CRISPR Application Development team at IDT. She received her Molecular Genetics & Biochemistry degree from Cornell University in 2006. Ashley has spent the last 18 years holding several roles in Research & Product Development teams at IDT. She has conducted research in RNAi and antisense oligo technologies, and more recently has focused on studying CRISPR gene editing, including high-throughput screening of CRISPR-Cas guide RNAs, optimizing the composition and delivery of synthetic RNA reagents complexed to recombinant CRISPR nucleases, and developing analysis solutions to understand the genetic outcomes following CRISPR gene editing.

Garrett Rettig, PhD, is the senior director of applied science for therapeutic oligos at IDT. His team focuses on deploying various CRISPR technologies—spanning editing to detection in an end-to-end workflow—to support customers in the preclinical and IND-enabling space through early-phase clinical trials.

Posters

Ashley Jacobi, our director of applications and market development, will speak about ___________ on April ___ at __ am/pm. She will discuss __________.

Adam Chernik, senior commercial product manager for genomic medicine & CRISPR, will present Improved Prediction and Activation of Homology-Directed Repair in Translational Ex-vivo Systems poster with poster number ________.

Ashley Jacobi, our director of applications and market development, will present _ Evolving solutions for effective genotoxicity assessment in CRISPR-based editing poster with poster number ________.

Garrett Rettig, our senior director of product development, will present Guide RNAs: Orthogonal Assessment of Purity and Identity poster with poster number ________.

Featured products

• CRISPR Gene Editing products